Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children

A. Drilon, T. W. Laetsch, S. Kummar, S. G. Dubois, U. N. Lassen, G. D. Demetri, M. Nathenson, R. C. Doebele, A. F. Farago, A. S. Pappo, B. Turpin, A. Dowlati, M. S. Brose, L. Mascarenhas, N. Federman, J. Berlin, W. S. El-Deiry, C. Baik, J. Deeken, V. BoniR. Nagasubramanian, M. Taylor, E. R. Rudzinski, F. Meric-Bernstam, D. P.S. Sohal, P. C. Ma, L. E. Raez, J. F. Hechtman, R. Benayed, M. Ladanyi, B. B. Tuch, K. Ebata, S. Cruickshank, N. C. Ku, M. C. Cox, D. S. Hawkins, D. S. Hong, D. M. Hyman

Research output: Contribution to journalArticlepeer-review

669 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children'. Together they form a unique fingerprint.

Medicine & Life Sciences